Established in 1992, ISCT, the International Society for Cell & Gene Therapy is a growing global organization of clinicians, regulators, researchers, technologists and industry partners with a shared vision to translate cell and gene therapies into safe and effective therapies to improve patients’ lives worldwide.
ISCT is the global leader focused on translational aspects of developing cell-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT provides a unique collaborative environment that addresses three key areas of clinical translation: Academia, Regulatory and Commercialization. Through long term strategic relationships with global regulatory agencies, academic institutions and industry partners, ISCT leads the advancement of research into clinical adoption and standard of care.
Comprised of over 1500 cell therapy experts across five geographic regions and representation from over 60 countries, ISCT members are part of a global community of peers, thought leaders and organizations invested in cell therapy translation. For more information about the organization, key initiatives and upcoming meetings, please visit: www.celltherapysociety.org, @ISCTglobal.